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Chemotaxis, migration toward soluble chemical
cues, is critical for processes such as wound healing
and immune surveillance and is exhibited by various
cell types, from rapidly migrating leukocytes to slow-
moving mesenchymal cells. To study mesenchymal
chemotaxis, we observed cell migration in microflui-
dic chambers that generate stable gradients of
platelet-derived growth factor (PDGF). Surprisingly,
we found that pathways implicated in amoeboid
chemotaxis, such as PI3K and mammalian target
of rapamycin signaling, are dispensable for PDGF
chemotaxis. Instead, we find that local inactivation
of Myosin IIA, through a noncanonical Ser1/2 phos-
phorylation of the regulatory light chain, is essential.
This site is phosphorylated by PKCa, which is acti-
vated by an intracellular gradient of diacylglycerol
generated by PLCg. Using a combination of live im-
aging and gradients of activators/inhibitors in the
microfluidic chambers, we demonstrate that this
signaling pathway and subsequent inhibition of
Myosin II activity at the leading edge are required
for mesenchymal chemotaxis.
INTRODUCTION
Chemotaxis, or directed cell migration toward a soluble cue, is a
critical process for many physiological events such as wound
healing, immune responses, and angiogenesis and has been
studied for nearly a century (Swaney et al., 2010). This process
is not limited to metazoans or even eukaryotes, as free-living
cells such as amoebae and bacteria must chemotax to find nu-
trients or more favorable environmental conditions (Sourjik and
Wingreen, 2012). Despite the long history of chemotaxis studies,
many important questions about how this process works and the
diversity of chemotactic mechanisms remain unresolved.
Chemotactic ligands can stimulate a variety of signaling path-
ways involving G protein-coupled receptors (GPCRs), receptor
tyrosine kinases (RTKs), and two-component histidine kinaseDevelopmepathways (Dormann and Weijer, 2006; Wadhams and Armitage,
2004). Of these, chemotaxis mediated by RTKs is the least well
understood. Platelet-derived growth factor (PDGF), epidermal
growth factor (EGF), vascular endothelial growth factor (VEGF),
and colony-stimulating factor 1 (CSF1) are among the chemoat-
tractants that elicit RTK-based chemotaxis of different cell types,
such as fibroblasts, epithelial and endothelial cells, and macro-
phages (Dormann and Weijer, 2006; Shamloo et al., 2008;
Webb et al., 1996). Although RTKs and GPCRs activate homolo-
gous enzymes (e.g., PI3K class 1A versus class 1B; PLCg versus
PLCb, respectively), it is unclear whether the same signaling
events are universally required for directed migration.
PDGF/PDGF receptor signaling is critical for mesenchymal
lineages during embryonic development and for tissue homeo-
stasis and wound repair and has been implicated in diseases
ranging from fibrosis to cancer (Andrae et al., 2008). The mesen-
chymal cells affected by PDGF signaling adhere firmly to extra-
cellular matrix and exhibit high contractility using bundled actin
stress fibers, limiting migration speed. Conversely, amoeboid
cells move rapidly (more than ten times faster thanmesenchymal
cells) without strong adhesion and with contractility confined
to the rear uropod. These different mechanics of migration cor-
respond to differing biological roles, with mesenchymal cells
participating in slow, collective responses in connective tissue,
whereas amoeboid cells such as leukocytes constitute a ‘‘rapid
response force.’’ Both types of cells exhibit chemotaxis, but it re-
mains an open question whether the underlying mechanisms at
the level of cytoskeletal dynamics and force generation are
similar (Bear and Haugh, 2014).
Measuring chemotaxis is a challenge, particularly for slow-
moving cells. Older methods such as the Boyden or transmem-
brane migration chamber have been widely used (Boyden,
1962), but suffer from certain shortcomings. Perhaps most sig-
nificant is that these measurements often do not distinguish be-
tween effects on the efficiency of migration (cell speed) versus
directional bias since treatments that affect either property might
be interpreted as an effect on ‘‘chemotaxis’’ (Zigmond and
Hirsch, 1973). In addition, these chamber systems do not allow
direct observation of the cells undergoing directed migration,
so the molecular processes involved cannot be imaged. Several
direct observation chemotaxis chambers have been developed
(Zicha et al., 1991; Zigmond, 1977); however, issues such as
limited gradient stability have restricted their application. Morental Cell 31, 747–760, December 22, 2014 ª2014 Elsevier Inc. 747
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make chambers in which gradients can be maintained for
many hours (Li Jeon et al., 2002; Shamloo et al., 2008).
Using such a microfluidic chamber, we recently tested the
ability of fibroblasts depleted of the Arp2/3 complex to chemotax
toward PDGF and EGF (Wu et al., 2012, 2013). The Arp2/3 com-
plex is a seven-subunit complex that forms branched actin struc-
tures found in lamellipodia; this function is actuated downstream
of certain chemotactic signaling pathways, including the afore-
mentioned PI3K (Rotty et al., 2013). Surprisingly, we found that
the Arp2/3 complex is dispensable for chemotaxis toward
PDGF or EGF, provided that the media are exchanged during
the experiment to flush out secreted factors produced by the
Arp2/3-depleted cells (Wu et al., 2013). It is notable that the
Arp2/3-depleted cells are unable to respond to surface-bound
gradients of extracellular matrix (haptotaxis), indicating that
RTK chemotaxis and haptotaxis have different requirements
for cytoskeletal organization and dynamics (Wu et al., 2012).
These results prompted us to probe the molecular mechanisms
that link signal transduction, elicited by RTK ligands such as
PDGF, to asymmetric force transduction by the cytoskeleton in
mesenchymal cells.
RESULTS
Signaling Pathways Implicated in Amoeboid Chemotaxis
Are Dispensable for Mesenchymal Chemotaxis to PDGF
To address themechanism of mesenchymal cell chemotaxis, we
utilized a microfluidic chemotaxis chamber system established
previously (Wu et al., 2012) (Figure 1Ai). In this system, we
routinely generate 1 mm long, linear gradients of growth factors
or small molecules that are stable for up to 24 hr and are compat-
ible with a variety of live-cell imaging techniques (Figures 1Aii
and 1Aiii). Tomeasure chemotaxis, cellsmigrating in the gradient
chambers were tracked (Movies S1 and S2 available online; Fig-
ure 1Bi), and information about migration speed, persistence,
and directionality was extracted from the tracks. The migration
speed and persistence (D/T ratio) were assessed by standard
methods (Figure S1A). Forward Migration Index (FMI), net dis-
tance moved in the direction of the gradient divided by total
path length, was used to quantify directionality (Figure S1A).
For the purposes of this study, we considered an FMI >0.1 to
indicate positive chemotaxis, FMI with a 95% confidence inter-
val encompassing zero to indicate no chemotaxis, and an FMI
<0.1 to indicate chemorepulsion. Directionality was repre-
sented graphically as circular, wind-rose histograms, where
the length of each leaflet corresponds to the percentage of cells
migrating in the direction of leaflet (Figure 1Bii). It is important to
note that wind-rose plots do not convey information about speed
or persistence of cell migration. Although many treatments
described in this study affected either migration speed or persis-
tence, there seemed to be little correlation with directionality as
reported by FMI. The relationship among these properties will be
pursued in a separate study, with this work remaining focused on
identifying the molecular pathway of directional sensing and
response in mesenchymal cells. The specific PDGF-R inhibitor,
AG-1296 (Kovalenko et al., 1997), blocked the chemotactic
response (Figure 1Biii), confirming the cognate mechanism of
the apparent PDGF gradient sensing.748 Developmental Cell 31, 747–760, December 22, 2014 ª2014 ElsWith this system, we sought to identify the pathway used by
slow-moving mesenchymal cells such as fibroblasts for PDGF
chemotaxis. Our previous results on the role of the Arp2/3
complex in chemotaxis relied on depletion by RNA interfer-
ence or by the chemical inhibitor CK-666, neither of which en-
sures complete elimination of Arp2/3 function (Wu et al., 2012).
To corroborate those findings, we assessed chemotaxis of
fibroblasts derived from a conditional knockout of the Arpc2
gene, which encodes the essential p34 subunit of the Arp2/3
complex. In accord with our previous results, genetic deletion
of Arp2/3 complex function does not block PDGF chemotaxis
in our chamber system (Figure 1C). Two pathways that have
been implicated in amoeboid chemotaxis are phosphoinosi-
tide 3-kinase (PI3K) and mammalian target of rapamycin
(mTOR) (Parent and Devreotes, 1999; Swaney et al., 2010;
Weiner, 2002). To determine whether these pathways are
required for fibroblast chemotaxis to PDGF, we treated cells
with inhibitors targeting either PI3K (PI3Ka inhibitor IV) or
mTOR (AZD8055) during the chemotaxis experiment. These
treatments block the expected signaling readouts effectively
(Figures S1B and S1C), but neither of them prevents PDGF
chemotaxis of fibroblasts (Figure 1D). PDGF chemotaxis in
the absence of PI3K signaling corroborates previous findings
(Melvin et al., 2011).
To extend these results, we turned to mesenchymal tumor
cells derived from genetically engineered murine models of mel-
anoma harboring oncogenic mutations in pathways implicated
in chemotaxis. The first cell line, LKB878, harbors two mutant
copies of K-Ras (G12D) and lacks the tumor suppressor LKB1
(Liu et al., 2012). The second cell line, PBT-2460, harbors a mu-
tation in B-Raf (V600E) and lacks PTEN (Hanna et al., 2013).
Both of these cell lines exhibit mesenchymal morphology,
with stress fibers and mature focal adhesions (Figure S1D).
We probed the pathways downstream of the PDGF receptor
in these cell lines. Compared with control fibroblasts, the
LKB878 cells showed elevated basal MEK/ERK signaling
without PDGF stimulation and further activation of this pathway
upon PDGF treatment. Akt activation appeared intact in this cell
line. Conversely, the PBT-2460 line showed substantial basal
phosphorylation of both MEK/ERK and Akt and no further stim-
ulation upon PDGF treatment (Figure 1E). When these cell lines
were analyzed in the microfluidic chambers, both displayed
robust PDGF chemotactic responses (Figure 1F). These data
suggest that mutations in these signaling pathways, which
affect amoeboid chemotaxis, do not affect mesenchymal
chemotaxis to PDGF.
Myosin IIA Is Required for Mesenchymal Chemotaxis
These data beg this question: what is required for mesenchymal
chemotaxis? One treatment that blocks PDGF chemotaxis in our
chamber system is the Myosin II inhibitor, blebbistatin (BLB; Fig-
ure 2A; Movie S3) (Straight et al., 2003). Although this drug alters
cell morphology and cytoskeletal structure, the speed of loco-
motion of BLB-treated fibroblasts was similar to that of untreated
controls (Figures 2A and 2B). The effects of BLB were reversible,
as chemotaxis resumed uponwashout of this drug and re-estab-
lishment of the PDGF gradient in the chamber (Figure 2A). Fibro-
blasts express two isoforms of Myosin II, MyoIIA and MyoIIB
(Even-Ram et al., 2007; Vicente-Manzanares et al., 2008). Toevier Inc.
Figure 1. Pathways that Are Dispensable for Mesenchymal Chemotaxis
(A) (i) A 3D schematic of the microfluidic chamber used for chemotaxis experiments. (ii) The fluorescent micrograph shows the formation of Cy5 dextran
gradient in the channel. (iii) A line scan of fluorescent intensity of the gradient indicates that a linear gradient is formed in the chamber with an approximate
slope of 43%.
(B) (i) Migratory tracks of IA32 fibroblast chemotaxing to a PDGF gradient. (ii) Cell tracks of chemotaxing cells represented as a wind-rose plot (number of cell
tracked [n] = 62). Each leaflet represents the count frequency of cells migrating in the corresponding angular bin. FMI, persistence (D/T), and velocity values are
indicated below the plot (±95% confidence interval). (iii) Wind-rose plot showing inhibition of chemotaxis to PDGF in the presence of a uniform concentration of
PDGF-R inhibitor, AG1296 (1 mM) (n = 68).
(C) Wind-rose plots of PDGF chemotaxis of WT (pre-Cre deletion) (n = 82) and Arpc2 KO (n = 71) MEFs.
(D) Directional migration response of fibroblasts to PDGF gradient in the presence of uniform PI3Ka inhibitor IV (5 mM) (n = 74) or mTOR inhibitor AZD8055 (1 mM)
(n = 56).
(E) Western blot analysis of fibroblasts and melanoma cells stimulated with PDGF for the indicated incubation times; ns indicates not serum starved.
Phosphorylation of ERK, MEK, Akt, and S6K1 was assessed.
(F) Chemotaxis of K-Ras/Lkb1 null (Melanoma 1) (n = 72) and B-Raf/Pten null (Melanoma 2) (n = 81) tumor cell lines to a PDGF gradient.
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Myosin IIA Inactivation Required for Chemotaxisconfirm and extend our BLB results, we depleted these isoforms
separately using multiple independent siRNAs. Whereas deple-
tion of MyoIIB did not affect chemotaxis, depletion of MyoIIA
ablated PDGF chemotaxis in fibroblasts (Figures 2C, S2A, and
S2B).DevelopmeNoncanonical Regulation of Myosin IIA via PKCa Is
Required for Mesenchymal Chemotaxis
We reasoned that PDGF chemotaxis might be governed by
asymmetric regulation of MyoIIA activity. The canonical pathway
of Myosin II regulation involves activating phosphorylation ofntal Cell 31, 747–760, December 22, 2014 ª2014 Elsevier Inc. 749
Figure 2. Myosin IIA Is Required for Chemo-
taxis, whereas Myosin IIB Is Dispensable
(A) Rose plot showing loss of chemotaxis in the
presence of uniform concentration of BLB (15 mM)
(n = 123) and recovery of chemotactic migration
after washout of BLB (n = 97).
(B) Immunofluorescence of IA32 fibroblasts shows
myosin light chain (GFP) and F-actin (red, Phalloi-
din) in cells before and after uniform BLB treat-
ment.
(C) Circular histograms showing chemotaxing
control cells, loss of chemotactic migration in
Myosin IIA KD (n = 80) cells, and intact chemotaxis
in Myosin IIB KD cells (n = 61).
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Myosin IIA Inactivation Required for ChemotaxisThreonine 18 and Serine 19 (Thr18/Ser19) on the regulatory light
chain (RLC; also known as MLC-20) of the Myosin II complex by
several kinases (Vicente-Manzanares et al., 2009) (Figure 3A).
However, consistent with previous studies (Komatsu and Ikebe,
2007), stimulation of fibroblasts with PDGF, PMA (phorbol ester),
or EGF produced no increase in Ser19 phosphorylation (Figures
3B and S3A). We also used correlative immunofluorescence to
image pSer19 RLC during chemotaxis in the chamber and
observed no bias in distribution of this modification relative to
the PDGF gradient (Figures S3B and S3C). To functionally
confirm that Thr18/Ser19 phosphorylation does not play a major
regulatory role in PDGF chemotaxis, we treated fibroblasts with
either ROCK or MLCK inhibitors (Y27632, peptide 18) to inhibit
the predominant kinases that phosphorylate Thr18/Ser19 in fi-
broblasts. Separately, neither of these treatments blocked
PDGF chemotaxis. Consistent with the need for some Myosin750 Developmental Cell 31, 747–760, December 22, 2014 ª2014 Elsevier Inc.II activity to execute chemotaxis, howev-
er, simultaneous inhibition of ROCK and
MLCK blocked PDGF chemotaxis (Fig-
ure 3C). Together, these data suggest
that the canonical regulatory pathway of
Myosin II is unlikely to play a major role
in PDGF chemotaxis and that a different
MyoIIA regulatory mechanism may be
required.
Aside from the canonical regulatory
pathway, Myosin II can also be regulated
by noncanonical pathways such as the
inhibitory phosphorylation of RLC on Ser-
ines 1 and 2 by conventional PKCs such
as PKCa (Figure 3A) (Bengur et al., 1987;
Ikebe et al., 1987; Kawamoto et al.,
1989; Komatsu and Ikebe, 2007; Nishi-
kawa et al., 1984; Varlamova et al.,
2001; Vicente-Manzanares et al., 2009).
To assess the role of Ser1/2 inhibitory
phosphorylation in PDGF chemotaxis,
we generated GFP fusions of the WT
RLC and a RLC mutant containing non-
phosphorylatable alanine substitutions
(S1AS2A) and expressed these in fibro-
blasts in a Dox-inducible manner. Upon
expression, neither theWT nor themutant
GFP fusions altered the phosphorylationof RLCSer19, with orwithout PDGF/PMA stimulation (Figure 3D).
Consistent with previous studies using PDGF, expression of the
S1AS2A RLC, but not the WT RLC, blocked the disassembly of
actin stress fibers in response to PMA treatment (Figure 3E) (Ko-
matsu and Ikebe, 2007). Expression of the S1AS2A dominant-
negative RLC blocked PDGF chemotaxis, whereas the WT
RLC construct did not affect this process (Figure 3F). These
data indicate that regulation of MyoIIA via Ser1/2 RLC inhibitory
phosphorylation is critical for PDGF chemotaxis.
Expression profiling showed that PKCa is the only conven-
tional PKC isoform expressed in IA32 fibroblasts (Wu et al.,
2013). To test whether or not PKCa is required for PDGF che-
motaxis in fibroblasts, we inhibited this kinase using the small
molecule inhibitor Go¨6976 (Martiny-Baron et al., 1993). This
compound blocked PDGF chemotaxis in a reversible manner
(Figure 4A). To corroborate this result, we depleted PKCa using
Developmental Cell
Myosin IIA Inactivation Required for Chemotaxismultiple independent siRNAs (Figure S4A) and confirmed that
this too blocks PDGF chemotaxis (Figures 4B and S4B). One
possibility is that PKCa activity is required for events unrelated
to directional migration, such as maintenance of a specific
gene expression pattern. To rule out this possibility, we gener-
ated a gradient of Go¨6976 in our microfluidic chamber system.
Fibroblasts in this gradient (without exogenous PDGF present)
display chemorepulsion, migrating away from the higher drug
concentration (Figure 4C). This result was confirmed using a
gradient of LY333531, a structurally unrelated conventional
PKC inhibitor (Figure S4C). Interestingly, cells expressing the
dominant-negative S1AS2A RLC construct were refractory to
the chemorepulsive effects of Go¨6976 (Figure 4C), as were cells
depleted of PKCa (Figure S4D). These data indicate that PDGF
chemotaxis in fibroblasts involves the regulation of MyoIIA activ-
ity via phosphorylation of the noncanonical, inhibitory Ser1/2
sites of RLC by PKCa.
Localized Diacylglycerol Production by PLCg Is
Required for Mesenchymal Chemotaxis
Conventional PKC isoforms such as PKCa are activated by a
combination of the membrane lipid diacylglycerol (DAG) and
cytosolic calcium (Ca2+) (Tanimura et al., 2002; Wu-Zhang and
Newton, 2013). The enzyme PLCg is activated directly by the
PDGF receptor and hydrolyzes the phosphoinositide PIP2 to pro-
duceDAGand IP3, and the latter inducesCa
2+ release from intra-
cellular stores (Hess et al., 1998). To test whether or not PLCg is
required for fibroblast chemotaxis to PDGF, we depleted PLCg1
(the only isoform expressed in IA32 fibroblasts) by multiple
siRNAs and, in parallel, utilized PLCg1/ MEFs and their
rescued derivative cell line (Figure S5A). Both depletion and
deletion of PLCg1 blocked PDGF chemotaxis (Figures 5A, 5B,
and S5B), indicating that signals generated by this enzyme are
critical for directional migration toward PDGF.
To assess the role of intracellular Ca2+ in PDGF chemotaxis,
we used pharmacological inhibition of several potential sources
of Ca2+. To block IP3-mediated release of Ca
2+ from intracellular
stores, we treated cells with Xestospongin-(c), a specific IP3 re-
ceptor inhibitor (Gafni et al., 1997). This treatment blocks
PDGF-induced Ca2+ increase in uniform application experiments
(data not shown) but did not block PDGF chemotaxis (Figure 5C).
To block mechanically sensitive Ca2+ channels, we treated cells
with Gd3+, a blocker of these channels (Yang and Sachs, 1989).
In the presence of multiple concentrations of Gd3+, chemotactic
responsewas intact, albeit with lower fidelity (Figure S5C). Simul-
taneous treatment with Xestospongin-(c) and Gd3+ arrested all
cell motility (data not shown), and therefore, we were unable to
test for an effect on chemotaxis. Together, while these data
confirm that cytosolic Ca2+ is important for overall cell motility,
they suggest that Ca2+ is unlikely to be a significant directional
determinant toward PDGF cues in our system.
To visualize the intracellular distribution of DAG, another signal
generated by PLCg in a PDGF gradient, we utilized a GFP-
tagged fragment of PKCg containing tandem C1 domains as a
translocation biosensor for DAG (Oancea et al., 1998). Since
our microfluidic chamber system allows high-resolution live-
cell imaging, we visualized this probe by total internal reflection
fluorescence (TIRF) microscopy. To verify the utility of this probe,
we expressed it in the PLCg1-depleted cells and observed noDevelopmemembrane recruitment of this probe to the ventral plasma mem-
brane (imaged by TIRF) upon uniform PDGF stimulation, but did
observe a bright signal with subsequent PMA stimulation (Fig-
ure S5D). When this probe was expressed in control cells and
imaged in a PDGF gradient, we observed a striking localization
of DAG to the upgradient portion of the cell that persisted for
hours (Figure 5D; Movie S4). Quantification of this localization
(see Supplemental Experimental Procedures; Figure S5E) across
many cells showed significant enrichment of this probe upgra-
dient, as compared with randomly migrating cells (Figures 5E
and 5F). These data indicate that DAG, produced locally by
PLCg1, is critical for fibroblast chemotaxis to PDGF.
Phorbol Ester PMAGradients Bypass the Need for PDGF
Receptors and PLCg, but Not PKCa or Myosin II,
Function
To functionally test the role of DAG in PDGF chemotaxis, we
generated a gradient of the DAG-mimetic PMA in our microflui-
dic chamber system (Figure 6A). Consistent with a positive,
instructive role for DAG in this pathway, fibroblasts exposed to
the PMA gradient migrated toward the higher concentration of
PMA (Figure 6B). This PMA ‘‘chemotaxis’’ was independent of
PDGF RTK activity, as it still occurred in the presence of the
PDGF-R inhibitor (Figure 6C). A PMA gradient also bypasses
the need for PLCg1, as shown by the positive migration of
PLCg1/ MEFs in this gradient (Figure 6C). However, PMA
was not able to bypass the need for PKCa or for Myosin II RLC
Ser1/2 phosphorylation in the directional migration response
(Figure 6D).
Localized Inactivation ofMyosin II at the Leading Edge Is
Sufficient to Promote Directional Migration
Our functional data support a model for PDGF chemotaxis that
involves localized inactivation of Myosin IIA on the upgradient
side of the cell via the PLCg1/PKCa/RLC (Ser1/2) pathway.
To visualize the organization of Myosin II during chemotaxis,
we imaged either the WT or S1AS2A form of the GFP-tagged
RLC by TIRF microscopy. Previous work has shown that Myosin
II has a characteristic pattern of supramolecular organization
from the leading edge of a mesenchymal cell toward the cell
body (Svitkina et al., 1997). At the edge, a soluble pool of Myosin
II accumulates into puncta or spots. These puncta coalesce into
bundled fiber-like structures consistent with localization to
stress fibers (Figure S6A). At the leading edge of chemotaxing fi-
broblasts expressing the WT RLC-GFP, we noted that puncta
are enriched, whereas actomyosin bundles are largely absent
(Movie S5, left panel). We developed an image analysis method
to segment and classify these structures using texture-based
approaches (see Supplemental Experimental Procedures; Fig-
ure S6B). To quantify the Myosin II organization, we averaged
the distribution of puncta and bundled structures acrossmultiple
cells in PDGF gradients. Consistent with our visual observations,
cells expressing the WT RLC-GFP showed increased puncta
and decreased stress fibers on the upgradient side of the cell
(Figure 7A), whereas S1AS2A-RLC-GFP showed even distribu-
tion of puncta and stress fibers around the perimeter of the cell
(Figure 7B; Movie S5, right panel).
To further challenge our hypothesis about localized inactiva-
tion of Myosin II during fibroblast chemotaxis, we exposed cellsntal Cell 31, 747–760, December 22, 2014 ª2014 Elsevier Inc. 751
Figure 3. Chemotaxis Requires Regulation of Myosin II Function via Noncanonical RLC Phosphorylation
(A) Schematic of Myo RLC showing phosphoregulatory sites Ser1/Ser2 and Thr18/Ser19. Ser1/Ser2 are inhibitory phosphorylation sites regulated by conven-
tional PKCa. Thr18/Ser19 are activating phosphorylation sites regulated by ROCK and MLCK.
(B) Western blot analysis to probe the extent of Ser19 phosphorylation of Myosin II RLC, which shows no change in response to PDGF or PMA stimulation.
(C) Wind-rose plots of cell migration show PDGF chemotaxis in the presence of either ROCK inhibitor Y27632 (15 mM) (n = 161) or MLCK inhibitor peptide 18
(10 mM) (n = 104). When added together, the ROCK and MLCK inhibitors impede chemotactic migration to PDGF (n = 94).
(legend continued on next page)
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Myosin IIA Inactivation Required for Chemotaxisto gradients of BLB in our microfluidic chamber system. It is
important to note that we used a lower concentration of this
drug in these gradient experiments than previous uniform treat-
ments (3 mM source,1.75 mM gradient midpoint). This cue pro-
moted the positive migration of fibroblasts toward the higher
concentration of BLB, although with a reduced FMI compared
with PDGF chemotaxis (Figure 7C; Movie S6, left panel). Uniform
BLB treatment caused disassembly of actin stress fibers in both
S1AS2A RLC-GFP- and WT RLC-GFP-expressing cells, consis-
tent with BLB acting at themolecular interface betweenMyosin II
and F-actin, downstream of Ser1/2 phosphoregulation (Figures
2B and S6C). Therefore, we reasoned that this gradient should
bypass the S1AS2A dominant-negative RLC. Indeed, cells ex-
pressing themutant construct showed positive migration toward
BLB (Figure 7C;Movie S6, right panel). We also imaged the local-
ization of Myosin II in the BLB gradients for bothWT and S1AS2A
RLC-GFP by TIRF microscopy. At these subsaturating BLB con-
centrations, stress fibers were reduced in the TIRF imaging, so
we concentrated on the puncta. Consistent with the observed
functional bypass by the BLB gradient, cells expressing either
WT or S1AS2A RLC-GFP showed increased puncta intensity
on the upgradient side of the cell (Figures 7D and S6D). Together,
these data indicate that localized inhibition of Myosin II by a
gradient of BLB is sufficient to provoke directional migration,
with movement biased in the direction of decreasing Myosin II
activity.
DISCUSSION
Using our direct observation chemotaxis chamber, we have
elucidated an obligate pathway formesenchymal chemotaxis to-
ward the RTK ligand PDGF (Figure 7E). The PDGF receptor, upon
activation, recruits PLCg to produce a localized intracellular
gradient of DAG. The critical enzyme that responds to this
gradient is PKCa, which phosphorylates RLC at Ser1/2 and
thus inactivates MyoIIA at the leading edge of the chemotaxing
cell. This localizedMyosin II inactivation provides the asymmetry
of force needed for directional migration. These results present a
significant step forward in our understanding of chemotaxis in
mesenchymal cells, but a number of questions arise from these
findings.
Asymmetric PDGF Receptor Signaling and Chemotaxis
PDGF receptors mobilize numerous signaling pathways via
recruitment of adaptor proteins and enzymes to their autophos-
phorylated cytoplasmic tails. Although many of the signaling
pathways downstream of the PDGF receptor are well under-
stood from a biochemical, structural, and kinetic perspective,
understanding how they are regulated in a cell experiencing
asymmetric stimulation as in chemotaxis presents a new set of
challenges. Not only must individual signaling components and
pathways be evaluated for their roles in chemotaxis, but also(D) Western blot analysis of Ser19 phosphorylation of Myosin II RLC after PDGF o
change in Ser19 phosphorylation of either the endogenous or GFP-tagged RLC.
(E) Immunofluorescence images of MyoRLC-GFP and MyoRLC(S1AS2A)-GFP c
myosin mutant cells upon PMA stimulation.
(F) Wind-rose plots showing chemotaxing control MyoRLC-GFP cells (n = 61) a
gradient.
Developmethe spatial and temporal aspects of this signaling must be
considered.
To break spatial symmetry, our data point to PLCg as the key
downstream enzyme that must be activated for fibroblasts to
chemotax toward PDGF. One of the products of this enzyme,
DAG, is maintained in a stable internal gradient within chemotax-
ing mesenchymal cells. Similar observations have recently been
made during collective cell migration of endothelial cells in
scratch assays (Tsai et al., 2014). This internal gradient can be
partially phenocopied by providing cells with an extracellular
gradient of the cell-permeable DAG analog, PMA. This suggests
that an internal gradient of DAG is both necessary and sufficient
to provide the asymmetric intracellular cue for chemotaxis. In
future studies, it will be important to investigate how this internal
gradient of DAG is maintained. Regulators of this internal
gradient are likely to include the DAG kinases, which convert
DAG into phosphatidic acid and thus limit the spatial range of
DAG diffusion in the plasma membrane. The other product of
PIP2 hydrolysis by PLCg is IP3. Based on our inhibitor studies,
the action of IP3 prompting Ca
2+ release from internal stores is
not required for PDGF chemotaxis, and neither is the action of
stretch-activated Ca2+ channels. These results stand in contrast
with a previous study implicating Ca2+ influx in the ability of fibro-
blasts to turn toward a PDGF gradient (Wei et al., 2009). As dis-
cussed in more detail below, certain signaling pathways might
allow cells to reorient toward a gradient more efficiently, while
at the same time being dispensable for chemotaxis. Intracellular
Ca2+ is likely to be important for directional migration in a variety
of other contexts. Indeed, in monolayer migration of endothelial
cells, pulses of Ca2+ have been shown to activate Myosin II ac-
tivity via MLCK to trigger retraction of the leading edge (Tsai
and Meyer, 2012). The context-dependent source, functional
role, and localization of Ca2+ during directional migration, and
its relationship to differential Myosin II activity, will require further
investigation.
Our studies have identified PDGF-R/PLCg/PKCa/
Myosin II as an obligate pathway for mesenchymal chemotaxis,
but other pathways activated by the PDGF receptor likely
contribute to the fidelity of this process and may prove to be
required for chemotaxis under different conditions, such as shal-
lower gradients (Bosgraaf et al., 2008). In support of this view,
gradients of PDGF elicited greater chemotactic fidelity than did
gradients of PMA, and still lower fidelity was promoted by gradi-
ents of BLB. This suggests that PI3K and possibly other signaling
pathways triggered by PDGF likely enhance chemotaxis and/or
the efficiency of the cells’ alignment with the gradient (Welf
et al., 2012) even though PI3K signaling, along with Rac (Mony-
penny et al., 2009) and the Arp2/3 complex (Wu et al., 2012), is
dispensable for executing this process.
A related question that arises is this: where is the amplifica-
tion found in our system? Stated another way, how does a
mesenchymal cell convert a fairly shallow gradient of receptorr PMA stimulation of both MyoRLC-GFP and MyoRLC(S1AS2A) cells shows no
ells show disassembly of actin stress fibers in WT cells and no disassembly in
nd nonchemotaxing mutant MyoRLC(S1AS2A)-GFP cells (n = 73) in a PDGF
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Figure 4. PKCa Is Essential for Chemotaxis
(A) Wind-rose plots of fibroblasts in a PDGF gradient show inhibition of
chemotaxis in the presence of a uniform concentration of PKCa inhibitor,
Go¨6967 (1 mM) (n = 162), and recovery of chemotaxis after drug washout
(n = 88).
(B) Circular histograms show chemotaxis of WT fibroblasts in a PDGF gradient
and the lack of chemotactic response of PKCa KD cells (n = 68) in the same
chamber.
(C) Chemorepulsion of WT cells to gradients of Go¨6967 (n = 101). Mutant
MyoRLC (S1AS2A) cells do not exhibit directional migration in a gradient of
Go¨6967 (n = 89).
Developmental Cell
Myosin IIA Inactivation Required for Chemotaxisoccupancy on the cell surface into a robust internal gradient that
leads to directed cell translocation? A common mechanism for
amplification of chemical signaling is positive cooperativity or
feedback (Iglesias and Devreotes, 2012; Jilkine and Edelstein-
Keshet, 2011). Such mechanisms at the level of PLC/PKC
signaling will need to be explored. One interesting candidate is754 Developmental Cell 31, 747–760, December 22, 2014 ª2014 Elsthe regulation of cofilin activity downstream of PLCg that has
been observed during EGF chemotactic signaling in adenocarci-
noma cells (Mouneimne et al., 2006). Downstream of this
pathway, another possible source of amplification is at the level
of myosin contractility itself. A relatively modest change in local
myosin activity could affect local F-actin organization in a
nonlinear manner, thus magnifying changes in myosin activity.
Further experiments are required to discriminate between these
and other possible mechanisms of amplification during mesen-
chymal chemotaxis toward RTK ligands.
Myosin II Regulation and Chemotaxis
At the heart of the pathway we have defined in this work is the
generation of asymmetric Myosin II activity by chemotactic
signaling. Although Myosin II activity has been linked to chemo-
taxis in amoeboid cells through genetic approaches, it has
always been considered a peripheral player in this process; how-
ever, our data establish a central role of Myosin II in mesen-
chymal chemotaxis. In some ways, the role of Myosin II in
chemotaxis is not surprising since it is one of the main force gen-
erators in cells (along with actin polymerization). The pathway we
have defined asymmetrically regulates Myosin II activity (and
thus asymmetric force generation) not by selective activation,
but by selective inactivation on the upgradient side of the cell.
Our data shed light on this problem and also raise several ques-
tions about how Myosin II is regulated and the role it plays in
crawling cells.
Myosin II activity can be regulated by a variety of mechanisms,
but the dominant mode of regulating this protein complex is
through activating phosphorylation of Thr18/Ser19 on the RLC.
Therefore, we were surprised to discover that this mechanism
is not responsive to PDGF stimulation and does not appear to
play a major role in PDGF chemotaxis. Instead, our data indicate
that noncanonical, inhibitory phosphorylation of RLC on Ser1/2
is critical for PDGF chemotaxis in fibroblasts. This inhibitory
phosphorylation of this site was discovered in the 1980s, but it
has received comparatively little attention relative to Thr18/
Ser19 phosphorylation. Although phosphorylation of Ser1/2 is
dispensable for cytokinesis in HeLa cells (Beach et al., 2011), it
is important for disassembly of stress fibers in response to
PDGF or PMA (Komatsu and Ikebe, 2007). Recently, phosphor-
ylation of Ser1/2 was identified as a critical regulatory mecha-
nism for T cell polarization (Liu et al., 2013). Unfortunately, the
molecular mechanism of the inhibitory effect of this phosphory-
lation is unknown. One proposed mechanism is that phosphory-
lation of Ser1/2 blocks or inhibits the phosphorylation of Thr18/
Ser19 by kinases such as rho-kinase (ROCK) or myosin light
chain kinase (MLCK) (Ikebe et al., 1987); however, our data argue
against that possibility.
How does asymmetric Myosin II activity lead to directed cell
migration? This question is likely to have a fairly complicated
answer. Myosin II is an abundant protein with a significant role
in organizing actin filament networks in cells, in addition to
generating contractile force through its motor activity (Vicente-
Manzanares et al., 2009). It is useful to consider the primary ef-
fects of Myosin II inhibition and the secondary consequences
of those primary effects. Two primary effects of Myosin II inhibi-
tion are alterations in actin organization and filament integrity.
Lower Myosin II activity will lead to slower formation of bundledevier Inc.
Figure 5. PLCg Is Essential for PDGF Chemotaxis and Produces an Asymmetric Pattern of Intracellular DAG
(A) Wind-rose plot of control cells migrating in a PDGF (n = 67) gradient and loss of directional migration of PLCg KD cells (n = 70) in the same chamber.
(B) Fibroblasts derived from PLCg null (PLCg1/) (n = 73) mice show a loss of chemotactic response to PDGF. Upon rescue of PLCg expression, these
fibroblasts regained their ability to chemotax (n = 101).
(C) Circular histogram of cells chemotaxing to PDGF gradients in a uniform concentration of Xestospongin-(c) (1 mM) (n = 69).
(D) Montage of an IA32 fibroblast transfected with GFP-tagged tandem C1 domain ((C1)2-GFP) chemotaxing to PDGF for more than 5 hr.
(legend continued on next page)
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Figure 6. Phorbol Ester PMA Gradients Bypass the Need for PDGF
Receptors and PLCg, but Not PKCa or Myosin II Function
(A) Schematic diagram of the putative chemotactic signaling pathway with
PMA bypass.
(B) Wind-rose plot of IA32 fibroblasts chemotaxing in PMA gradients (n = 89).
(C) Wind-rose plots show that PMA gradients rescue chemotaxis of both IA32
fibroblasts in a uniform concentration of PDGF-R inhibitor AG1296 (1 mM) (n =
45) and that of PLCg1/ fibroblasts (n = 61).
(D) Circular histograms showing no rescue of chemotaxis of PKCa KD (n = 85)
or mutant Myo-RLC(S1AS2A) cells (n = 187) in PMA gradients.
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loose filament networks at the lamellipodium/lamella boundary.
Myosin II activity has also been linked to actin filament severing
(Wilson et al., 2010), and reduced severing in the upgradient side(E) Enriched pixels in a chemotaxing cell are shown outlined inmagenta. The intens
point to create a signaling ‘‘map’’ with the angle plotted on the horizontal axis and
distribution in chemotaxing cells expressing (C1)2-GFP (n = 12 cells).
(F) Enriched pixels in a randomly migrating cell are shown outlined in magenta. T
each time point to create a signaling ‘‘map’’ with the angle plotted on the hori
intracellular DAG distribution in randomly migrating cells expressing (C1)2-GFP (
756 Developmental Cell 31, 747–760, December 22, 2014 ª2014 Elsof the cell could locally alter actin dynamics. The secondary ef-
fects of these changes could be slower actin retrograde flow
and altered protrusion and focal adhesion dynamics. In a cell un-
dergoing chemotaxis, these changes are biased by the PLCg/
PKCa pathway to the upgradient side of the cell, leading to the
observed bias in cell translocation. Another possible outcome
is that global gradients in Myosin II activity will result in higher
overall contractility in the downgradient side of the cell, promot-
ing the squeezing of cellular contents toward the upgradient side.
Chemotaxis across Diverse Cell Types: Different
Molecules, Same Principles?
One of the main findings in this paper is that mesenchymal cells
such as fibroblasts use a molecular pathway for chemotaxis that
is different than the pathways used by amoeboid cells. This
finding highlights the diversity of chemotactic mechanisms that
operate in different cell types. One possible source of this differ-
ence is the way that each cell type utilizes Myosin II. In mesen-
chymal cells, which are much more adherent, Myosin II is found
throughout the cell and controls contractile stress fiber networks
that span the cell from front to back. In amoeboid cells, which are
far less adherent, Myosin II is largely confined to the rear uropod,
and no stress fibers are present. Therefore, mesenchymal cells
may be particularly sensitive to mechanisms that locally control
Myosin II activity. Another difference is the types of receptors
that trigger the chemotactic response. Although some amoeboid
cells are capable of responding to both RTK and GPCR ligands
(Park et al., 2011), the vast majority of studies on amoeboid
chemotaxis has focused on GPCR ligands such as fMLP in neu-
trophils or extracellular cAMP for Dictyostelium cells. It will be
interesting to examine RTK-driven chemotaxis in amoeboid cells
or GPCR chemotaxis in mesenchymal cells. Unfortunately, ex-
amination of the transcriptome generated by RNA-Seq has not
revealed obvious candidate chemotactic GPCRs expressed in
our fibroblasts (unpublished data). Finally, our data indicate
that perturbing a single pathway (PLCg/PKCa/Myosin IIA)
in fibroblasts is sufficient to disrupt chemotaxis, whereas genetic
studies in Dictyostelium amoebae have revealed a striking func-
tional redundancy among at least five separate pathways in
response to chemotactic stimulation (Swaney et al., 2010).
Although we do not yet understand the difference between these
two contexts, we speculate that the need for Dictyostelium cells
to aggregate by chemotaxis under nutrient-poor conditions cre-
ates an intense selective pressure for redundancy.
Although the chemotactic pathway defined here for mesen-
chymal cells apparently uses different molecular players than
amoeboid cells to achieve directed migration, it is worth consid-
ering the conceptual and functional similarities between these
pathways. In both cases, soluble extracellular cues activate cell
surface receptors in an asymmetric fashion. The signals must
be converted into intracellular gradients of second messenger
or intermediate molecules. This signaling module must be adeptity values of the segmented pixels are summedwithin angular bins at each time
time on the vertical axis. Histogram showing the cumulative intracellular DAG
he intensity values of the segmented pixels are summed within angular bins at
zontal axis and time on the vertical axis. Histogram showing the cumulative
n = 13 cells).
evier Inc.
Figure 7. Asymmetric Myosin II Organization and Activity Are Hallmarks of Chemotactic Migration in Mesenchymal Cells
(A) TIRFmicroscopymovies of chemotaxingMyoRLC-GFP cells are analyzed to identify puncta (blue) and stress fiber regions (red). The localization of puncta and
stress fibers relative to the cell centroid were averaged across multiple cells (n = 11 cells) and presented as histograms.
(B) Analysis of puncta and stress fiber distributions, quantified as in (A), in MyoRLC(S1AS2A)-GFP cells (n = 36 cells).
(C) Circular histograms of MyoRLC-GFP (n = 162) and MyoRLC(S1AS2A) (n = 67) cells chemotaxing in a gradient of BLB.
(D) Intensity of MyoRLC-GFP and MyoRLC(S1AS2A)-GFP during chemotaxis in a BLB gradient, presented as a histogram.
(E) Proposed model of PDGF chemotaxis: PDGF binds to PDGFR and recruits PLCg to produce a localized intracellular gradient of DAG. The asymmetric DAG
phosphorylates RLC at Ser1/2 via PKCa, inactivating MyoIIA at the leading edge of the chemotaxing cell. This localized Myosin II inactivation provides the
asymmetry of force needed for directional migration.
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Myosin IIA Inactivation Required for Chemotaxisat both maintaining a robust pattern in the presence of long-term
extracellular cues and changing rapidly to respond to new, acute
stimuli, and it must effectively interface with the cytoskeletal
network to produce the asymmetric force needed for directed
cell translocation. In amoeboid cells, this force appears to be
generated by actin polymerization in the protrusive pseudopod,
whereas in mesenchymal cells, asymmetric force is generated
by selective inactivation of Myosin II near the leading edge. A
particularly intriguing problem in both instances is how the cyto-
skeletal or force-generatingmodule feeds back into the signaling
module to reinforce and refine directional migration.
EXPERIMENTAL PROCEDURES
For complete methods, see the Supplemental Experimental Procedures found
in the Supplemental Information.
Cell Culture, Viral Transduction, and Plasmid/siRNA Transfections
Cells were cultured in DMEM supplemented with 10% FBS (HyClone),
100 U/ml penicillin, 100 mg/ml streptomycin, and 292 mg/ml L-glutamine. Retro-
viral packaging, infections, and fluorescence-activated cell sorting were per-
formed as described (Bear et al., 2000). Lentivirus production and infection
were performed as described (Cai et al., 2008). K-Ras;LKB1/ cells,
B-Raf;Pten/ cells, and PLCg1/, PLCg1 rescue cells were kind gifts from
Sharpless lab (UNC-CH), Kim lab (UNC-CH), and Sondek lab (UNC-CH),
respectively. Cells expressing tagged tandem C1 domains were generated
by transient transfection protocols, and Myosin II, PKC, and PLC knockdown
cells were generated using standard siRNA knockdown protocols. Arpc2/
fibroblasts were generated from tail tissue of mice harboring a floxed Arpc2
allele in the Ink4a/Arf/ genetic background.
Generation of MyoRLC-GFP Cell Lines
pLL6-MYH12A construct was made by replacing 50LTR promoter in pLL5.0
(Cai et al., 2008) with PTight promoter from pTRE-Tight Vector (Clontech) and
inserting human MYH12A using EcoRI-BamHI cloning sites. MYH12A insert
was obtained by PCR from cDNA isolated from human cell line WM-266-4
(ATCC CRL-1676). Point mutations in MYH12A were introduced using stan-
dard overlap extension technique using KOD polymerase (EMD Millipore).
Tetracycline-inducible MYH12A WT and S1AS2A mutant IA32 cell lines were
made by first preparing a stable rtTA-expressing IA32 cells using pLenti-
CMV-rtTA3-hygro lentivirus infection (virus made with Addgene plasmid
26730) and selection with 100 mg/ml hygromycin. These stable rtTA cells
were then infected with pLL6-MYH12A-GFP lentivirus and subjected to three
rounds of FACS: first, cells were induced with 1 mg/ml Doxycycline (Dox) and
sorted for GFP-positive cells. The resulting cell population was then allowed to
recover to uninduced state in absence of Dox and sorted for no GFP expres-
sion, and finally, the cell population obtained after this sort was induced with
1 mg/ml Dox again and sorted for high GFP expression. Resulting Tet-inducible
MLC populations were induced with 1 mg/ml Doxycyclene for 24 hr before
chemotaxis experiments.
Directional Migration Image Acquisition and Analysis
Polydimethylsiloxane microfluidic devices were prepared as described previ-
ously (Wu et al., 2012). Chemotaxis assays were performed on an Olympusmi-
croscope with a 203 objective using Metamorph imaging software. Images
were collected every 10 min for up to 24 hr. Individual cells were manually
tracked using ImageJ software (Manual Tracking plugin). Only viable and
visibly migrating cells (net path length >50 mm) were tracked during the exper-
iments. The tracks obtained were analyzed using the Chemotaxis Tool ImageJ
plugin (http://www.ibidi.de/applications/ap_chemotaxis.html#imageanalysis).
This analysis tool was used to extract the FMI along with the velocity of migra-
tion and the persistence of migration using the D/T ratio (net path length/total
path length). Further, the plugin also generates histograms (count frequency) of
migration direction of cells for each data set. The secplot function of Matlab
was then used to generate rose plots of directionalmigration on normalized po-
lar coordinates where the outer most ring corresponds to frequency (r) of 8%.758 Developmental Cell 31, 747–760, December 22, 2014 ª2014 ElsAnalysis of the DAG Pattern
To correlate the intensity of DAG in a cell and direction of chemotaxis, a
signaling map of the tandem C1 probe was created. These fluorescent inten-
sity maps were created for each cell by a process of thresholding, masking,
and segmenting within angular bins relative to cell centroid (Supplemental
Experimental Procedures; Welf et al., 2012). The normalized pattern is then
averaged over all the cells for each condition to produce an aggregate plot.
The linear (unbinned) plots are smoothed by local regression using weighted
linear least-squares and a first-degree polynomial mode. The cumulative
DAG signal is then presented as a histogram with a bin size of 10 degrees
for chemotaxing cells (n = 12 cells) and randomly migrating (n = 13 cells) (Fig-
ures 5E and 5F). A similar approach was used to analyze the distribution of
pSer19 of RLC in chemotaxing cells (Figure S3B).
Analysis of Myosin II Organization
Analysis similar to the one described above was used. Due to the obscured
visibility and discontinuity of the cell outline in cells expressing RLC-GFP con-
structs, a convex hull was created around the original cell mask. Using 2Dme-
dian filtering (Figure S6B1), puncta (Figure S6B2) and stress fibers in the outer
ring of the convex hull mask are segmented. Each of the pixels associated with
puncta and stress fibers are assigned to an angular bin with respect to the cell
centroid (one count per pixel); any bin containing both puncta and stress fibers
are counted as stress fibers. Plots are then generated in the same manner as
described above for the DAGpattern (see Supplemental Information). The data
for the WT RLC-GFP-expressing cells in the PDGF gradient are shifted by the
median angle of migration (not including angles more than 90 from the direc-
tion of the PDGF gradient), resulting in a 25-degree shift to the right. During
migration in response to a BLB gradient, very few stress fibers were visible un-
der TIRF imaging. Analysis was therefore performed in the samemanner as for
the DAG pattern to quantify RLC-GFP regions at the cell periphery.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and six movies and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2014.10.024.
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